MedPath

REITHERA SRL

REITHERA SRL logo
🇮🇹Italy
Ownership
Holding
Established
2005-01-01
Employees
101
Market Cap
-
Website
http://www.reithera.com

Clinical Trials

7

Active:0
Completed:7

Trial Phases

2 Phases

Phase 1:6
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 1
6 (85.7%)
Phase 2
1 (14.3%)

Study of GRAd-COV2 for the Prevention of COVID-19 in Adults

Phase 2
Completed
Conditions
Covid19
First Posted Date
2021-03-10
Last Posted Date
2023-03-29
Lead Sponsor
ReiThera Srl
Target Recruit Count
10300
Registration Number
NCT04791423
Locations
🇮🇹

Ospedale Vittorio Emanuele Ii, Bisceglie, Barletta- Andria-Trani, Italy

🇮🇹

Istituto per le Malattie Infettive Lazzaro Spallanzani IRCCS, Roma, RM, Italy

🇮🇹

Azienda Ospedaliera San Giuseppe Moscati, Avellino, Italy

and more 23 locations

Phase I Study to Assess the Safety and Immunology of a COVID-19 Vaccine With GRAd-COV2 Vaccine

Phase 1
Completed
Conditions
COVID-19
First Posted Date
2020-08-27
Last Posted Date
2022-02-08
Lead Sponsor
ReiThera Srl
Target Recruit Count
98
Registration Number
NCT04528641
Locations
🇮🇹

INMI Spallanzani, Rome, Italy

🇮🇹

Centro Ricerche Cliniche, Verona, Italy

RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections.

Phase 1
Completed
Conditions
Respiratory Syncytial Virus Infections
First Posted Date
2013-03-06
Last Posted Date
2016-04-26
Lead Sponsor
ReiThera Srl
Target Recruit Count
72
Registration Number
NCT01805921
Locations
🇬🇧

Centre for Clinical Vaccinology & Tropical Medicine (CCVTM), Oxford, Oxfordshire, United Kingdom

Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients

Phase 1
Completed
Conditions
Hepatitis C
First Posted Date
2012-10-05
Last Posted Date
2013-08-29
Lead Sponsor
ReiThera Srl
Target Recruit Count
9
Registration Number
NCT01701336
Locations
🇮🇹

Azienda Ospedaliera Universitaria di Pisa. Ospedale di Cisanello, Pisa, Italy

🇮🇹

Azienda Ospedaliera Universitaria Pisana. Ospedale di Santa Chiara, Pisa, Italy

Study of a New MVA Vaccine for Hepatitis C Virus

Phase 1
Completed
Conditions
Hepatitis C Infection
First Posted Date
2011-02-15
Last Posted Date
2016-04-26
Lead Sponsor
ReiThera Srl
Target Recruit Count
55
Registration Number
NCT01296451
Locations
🇬🇧

Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom

🇬🇧

John Radcliffe Hospital, Headley Way, Headington, Oxford, United Kingdom

🇬🇧

Wycombe Hospital, High Wycombe, Buckinghamshire, High Wycombe, United Kingdom

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.